Ibrexafungerp: A First-in-Class Oral Triterpenoid Glucan Synthase Inhibitor
| Publication | Article in Journal of Fungi, published February 2021 |
|---|---|
| Authors | Sabelle Jallow, Nelesh P. Govender |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…